658
Views
24
CrossRef citations to date
0
Altmetric
Review

Management and therapeutic perspectives in amyotrophic lateral sclerosis

, , , , &
Pages 263-276 | Received 31 Mar 2016, Accepted 19 Aug 2016, Published online: 20 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Martinez, Maria del Valle Palomo Ruiz, Daniel I. Perez & Carmen Gil. (2017) Drugs in clinical development for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 26:4, pages 403-414.
Read now

Articles from other publishers (23)

Kateřina Klíčová & Jan Mareš. (2023) Molecular and cellular biology of amyotrophic lateral sclerosis. Neurologie pro praxi 24:1, pages 50-53.
Crossref
Alexandria L. Sohn, Lingyan Ping, Jonathan D. Glass, Nicholas T. Seyfried, Emily C. Hector & David C. Muddiman. (2022) Interrogating the Metabolomic Profile of Amyotrophic Lateral Sclerosis in the Post-Mortem Human Brain by Infrared Matrix-Assisted Laser Desorption Electrospray Ionization (IR-MALDESI) Mass Spectrometry Imaging (MSI). Metabolites 12:11, pages 1096.
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Oihane Pikatza-Menoio, Amaia Elicegui, Xabier Bengoetxea, Neia Naldaiz-Gastesi, Adolfo López de Munain, Gorka Gerenu, Francisco Javier Gil-Bea & Sonia Alonso-Martín. (2021) The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. Journal of Personalized Medicine 11:7, pages 671.
Crossref
Elisabeth Traiffort, Séverine Morisset-Lopez, Mireille Moussaed & Amina Zahaf. (2021) Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 22:7, pages 3426.
Crossref
Ali Yousefian-Jazi, YunHee Seol, Jieun Kim, Hannah L. Ryu, Junghee Lee & Hoon Ryu. (2020) Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis. Cells 9:12, pages 2687.
Crossref
Simone P. Norris, Marie-France N. Likanje & Jinsy A. Andrews. (2020) Amyotrophic lateral sclerosis: update on clinical management. Current Opinion in Neurology 33:5, pages 641-648.
Crossref
Martin Matharan, Stéphane Mathis, Sarah Bonabaud, Louis Carla, Antoine Soulages & Gwendal Le Masson. (2020) Minimizing the Diagnostic Delay in Amyotrophic Lateral Sclerosis: The Role of Nonneurologist Practitioners. Neurology Research International 2020, pages 1-8.
Crossref
Luana Saba, Maria Teresa Viscomi, Alessandro Martini, Silvia Caioli, Nicola Biagio Mercuri, Ezia Guatteo & Cristina Zona. (2019) Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations. Neurobiology of Disease 130, pages 104532.
Crossref
Joel Gruchot, David Kremer & Patrick Küry. (2019) Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses. Frontiers in Genetics 10.
Crossref
Takenari Yamashita & Shin Kwak. (2019) Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS. Neuroscience Research 144, pages 4-13.
Crossref
Stéphane Mathis, Cyril Goizet, Antoine Soulages, Jean-Michel Vallat & Gwendal Le Masson. (2019) Genetics of amyotrophic lateral sclerosis: A review. Journal of the Neurological Sciences 399, pages 217-226.
Crossref
Gitika Batra, Manav Jain, RahulSoloman Singh, AmitRaj Sharma, Ashutosh Singh, Ajay Prakash & Bikash Medhi. (2019) Novel therapeutic targets for amyotrophic lateral sclerosis. Indian Journal of Pharmacology 51:6, pages 418.
Crossref
Efthimios DardiotisVasileios SiokasMaria SokratousZisis TsourisAthina-Maria AloizouDesponia FlorouMetaxia DastamaniAlexios-Fotios A. MentisAlexandros G. Brotis. (2018) Body mass index and survival from amyotrophic lateral sclerosis. Neurology Clinical Practice 8:5, pages 437-444.
Crossref
Melanie Harris, Geoff Thomas, Mary Thomas, Paul Cafarella, Allegra Stocks, Julia Greig & R. Doug McEvoy. (2017) Supporting wellbeing in motor neurone disease for patients, carers, social networks, and health professionals: A scoping review and synthesis. Palliative and Supportive Care 16:2, pages 228-237.
Crossref
Ina Dervishi & P. Hande Ozdinler. (2018) Incorporating upper motor neuron health in ALS drug discovery. Drug Discovery Today 23:3, pages 696-703.
Crossref
Stéphane Mathis & Gwendal Le Masson. (2018) RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis. Biomedicines 6:1, pages 9.
Crossref
Piotr Czarny, Paulina Wigner, Piotr Galecki & Tomasz Sliwinski. (2018) The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 309-321.
Crossref
Amit Kumar Halder, Ana S. Moura & M. Natália D. S. Cordeiro. 2019. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. Multi-Target Drug Design Using Chem-Bioinformatic Approaches 155 186 .
Ting Zhou, Tina Khorshid Ahmad, Kiana Gozda, Jessica Truong, Jiming Kong & Michael Namaka. (2017) Implications of white matter damage in amyotrophic lateral sclerosis. Molecular Medicine Reports 16:4, pages 4379-4392.
Crossref
Matthias Boentert, Stephan Wenninger & Valeria A. Sansone. (2017) Respiratory involvement in neuromuscular disorders. Current Opinion in Neurology 30:5, pages 529-537.
Crossref
Alice Ford HarrisonJames Shorter. (2017) RNA-binding proteins with prion-like domains in health and disease. Biochemical Journal 474:8, pages 1417-1438.
Crossref
Rawan Eid, Nagla T.T. Arab & Michael T. Greenwood. (2017) Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:2, pages 399-430.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.